S&P 500
7,226.20
+0.01%
Dow Jones
49,494.60
-0.62%
Nasdaq 100
27,685.40
+0.66%
Russell 2000
2,804.78
-0.02%
FTSE 100
10,364.50
0.00%
Nikkei 225
59,260.50
-0.78%

Investing

TSHA logo Taysha Gene Therapies : TSHA

TSHA

Stock Data

$6.33

Change down

$0.06 (0.94%)

Asset Type

Common Stock

Exchange

NASDAQ

Currency

USD

Country

USA

Sector

HEALTHCARE

Industry

BIOTECHNOLOGY

Taysha Gene Therapies Inc is a pioneering firm based in Dallas, Texas, dedicated to advancing gene therapy. The company specializes in creating innovative treatments for rare diseases of the central nervous system using adeno-associated virus technology. Its portfolio includes promising therapies for conditions like giant axonal neuropathy, Rett syndrome, and various forms of Batten disease. Taysha Gene Therapies works closely with The University of Texas Southwestern Medical Center, aiming to transform the lives of patients with monogenic diseases through cutting-edge gene therapy solutions.

All Taysha Gene Therapies Articles

1 Article